Drug factory · FDA FEI 3007934434

Partner Therapeutics, Inc.

2625 162nd Street SW, Lynnwood, WA, United States

United States: 1

Problems found, fixed voluntarily at FDA's last inspection, Jul 22, 2022.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

6 drug inspections on record since 2009: 0 with no problems, 5 with problems fixed voluntarily, 1 with FDA action.

What it does, for whom

DrugRoleForNDC
SargramostimMakes the active ingredient and tests it Partner Therapeutics, Inc. 71837-5843

FDA inspection history

EndedResultProgramProblems noted
Jul 22, 2022Problems found, fixed voluntarilyDrug Quality Assurance—
Nov 18, 2016Problems found, fixed voluntarilyDrug Quality Assurance—
Aug 26, 2016Problems found, fixed voluntarilyDrug Quality Assurance—
Mar 18, 2015Serious problems, FDA actionDrug Quality Assurance—
May 24, 2013Problems found, fixed voluntarilyDrug Quality Assurance—
Oct 28, 2009Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis; api manufacture.